ebomi
Colour theme
Sign in
Insider · CIK 0001356950

Scopa James Paul

CIK 0001356950 Name as filed on the most recent filing

Filed as Scopa James Paul (25)

36 transaction lines · from 25 filings · filed 2007-01-05 to 2024-02-09 The span is the filing dates this catalog holds, not the entity's full filing history. Absence here is not evidence of absence at the SEC.

How this page attributes a trade

A line appears here when the filing that carries it names this CIK as a reporting owner, not only when the parser picked this CIK as the line's primary owner. That is why a joint filing appears on both owners' pages rather than vanishing from the second one. The catalog never merges two CIKs into one person and never splits one CIK into two: identity here is the SEC's own identifier and nothing else.

01

Issuers this insider has filed against

Ordered by last-seen filing date, newest first. Roles are as filed on the Form 4 and are not normalised.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

No issuer is recorded

The catalog holds no filing linking this CIK to an issuer.

02

Transactions

Every stored Form 4 line naming this reporting owner, newest transaction date first. Each row links to the filing it came from.

22 transactions · Newest transaction date first, id breaking the tie.

Fault

This container could not be filled from the store. It is showing nothing because a read failed, not because no insider filed: those are different facts and this catalog will not let one stand in for the other. The last ingest the store recorded was 2026-08-22 05:23 UTC.

Transactions filed by this insider
Direction Date Code Company Value USD Filing
2024-02-07 P, Open-market purchase Adverum Biotechnologies, Inc.ADVM 135,000, acquired Open Form 4 filing 0001415889-24-003209
2023-03-17 S, Open-market sale Dice Therapeutics, Inc.DICE 290,500, disposed Open Form 4 filing 0001209191-23-020299
2021-11-15 S, Open-market sale Adverum Biotechnologies, Inc.ADVM 109,000, disposed Open Form 4 filing 0001209191-21-065115
2021-09-15 P, Open-market purchase Dice Therapeutics, Inc.DICE 102,000, acquired Open Form 4 filing 0001209191-21-056526
2020-02-14 P, Open-market purchase Adverum Biotechnologies, Inc.ADVM 137,500, acquired Open Form 4 filing 0001209191-20-009848
2019-05-06 P, Open-market purchase Adverum Biotechnologies, Inc.ADVM 134,200, acquired Open Form 4 filing 0001209191-19-027832
2014-03-10 S, Open-market sale Aratana Therapeutics, Inc.PETX 12,012,000, disposed Open Form 4 filing 0001209191-14-020007
2014-02-10 S, Open-market sale Epizyme, Inc.EPZM 13,649,981, disposed Open Form 4 filing 0001209191-14-009076
2013-07-30 P, Open-market purchase Conatus Pharmaceuticals IncCNAT 1,817,915, acquired Open Form 4 filing 0001209191-13-038632
2013-07-02 P, Open-market purchase Aratana Therapeutics, Inc.PETX 3,000,000, acquired Open Form 4 filing 0001209191-13-034981
2013-03-11 S, Open-market sale Pacira Pharmaceuticals, Inc.PCRX 13,930,000, disposed Open Form 4 filing 0001209191-13-016170
2012-02-01 P, Open-market purchase Verastem, Inc.VSTM 1,000,000, acquired Open Form 4 filing 0001209191-12-007620
2011-11-21 P, Open-market purchase Pacira Pharmaceuticals, Inc.PCRX 2,999,997, acquired Open Form 4 filing 0001209191-11-057585
2011-02-08 P, Open-market purchase Pacira Pharmaceuticals, Inc.PCRX 2 lines 3,749,998, acquired Open Form 4 filing 0001209191-11-010540
2009-02-12 P, Open-market purchase Peplin IncPLI 10,242, acquired Open Form 4 filing 0001209191-09-008569
2009-02-11 P, Open-market purchase Peplin IncPLI 7,992, acquired Open Form 4 filing 0001209191-09-008569
2009-02-09 P, Open-market purchase Peplin IncPLI 7,992, acquired Open Form 4 filing 0001209191-09-007928
2009-02-05 P, Open-market purchase Peplin IncPLI 20,654, acquired Open Form 4 filing 0001209191-09-007151
2009-01-27 P, Open-market purchase Peplin IncPLI 2 lines 13,716, acquired Open Form 4 filing 0001209191-09-005047
2009-01-23 P, Open-market purchase Peplin IncPLI 48,232, acquired Open Form 4 filing 0001209191-09-005047
2009-01-22 P, Open-market purchase Peplin IncPLI 2 lines 20,914, acquired Open Form 4 filing 0001209191-09-004702
2009-01-21 P, Open-market purchase Peplin IncPLI 7,456, acquired Open Form 4 filing 0001209191-09-004702
2009-01-20 P, Open-market purchase Peplin IncPLI 378, acquired Open Form 4 filing 0001209191-09-003983
2009-01-19 P, Open-market purchase Peplin IncPLI 7,372, acquired Open Form 4 filing 0001209191-09-003983
2009-01-16 P, Open-market purchase Peplin IncPLI 60,188, acquired Open Form 4 filing 0001209191-09-003983
2009-01-15 P, Open-market purchase Peplin IncPLI 12,464, acquired Open Form 4 filing 0001209191-09-003983
2009-01-13 P, Open-market purchase Peplin IncPLI 48,584, acquired Open Form 4 filing 0001209191-09-003411
2007-09-14 S, Open-market sale Memory Pharmaceuticals CorpMEMY 57,960, disposed Open Form 4 filing 0001209191-07-053964
2007-09-13 S, Open-market sale Memory Pharmaceuticals CorpMEMY 132,120, disposed Open Form 4 filing 0001209191-07-053453
2007-09-12 S, Open-market sale Memory Pharmaceuticals CorpMEMY 21,611, disposed Open Form 4 filing 0001209191-07-053453
2006-12-18 P, Open-market purchase Memory Pharmaceuticals CorpMEMY 2,569,818, acquired Open Form 4 filing 0001181431-07-002395

This column is intentionally blank

No transaction line is stored for this reporting owner, though the catalog holds filings naming them. That happens when the filings report only holdings or only positions the store does not carry, and when a parse failed; each filing page states its own parse status.

Search the catalog
Codes on this page
P, Open-market purchase
Open-market purchase
S, Open-market sale
Open-market sale
Relationships on this page
D, Director
Director

Every value is as reported on the Form 4, totalled to the dollar. Share counts, the price per share and the full list of reporting owners are on each filing's own page, which every row here opens. A row marked n lines adds up that many filed lines of one filing, on one day, on one side of the market; a filing whose lines fall across two pages is left as its lines on both, so no total here is ever short.

What this insider's stored lines contain

Exact counts over every stored line for this entity. This is a statement of composition, not a filter: the only filter this page offers is the open-market one above, because that is the only one an index serves today.

  • Open-market purchase 20
  • Open-market sale 2
  • Option exercise 0
  • Grant or award 0
  • Tax withholding 0
  • Disposition to the issuer 0
  • In-the-money option exercise 0

How to cite this page

ebomi catalog. Scopa James Paul, insider transactions. Retrieved 2026-08-23 from https://ebomi.com/insider/0001356950

Balogh, A. Insider trading. Scientific Data 10, 237 (2023) doi:10.1038/s41597-023-02147-6

This page as JSON The JSON twin is shaped by the same read model as this page, so the two cannot disagree. Its envelope carries the canonical URL, the retrieval time, the coverage claim, and the licence statement.